2017
DOI: 10.1111/jvp.12455
|View full text |Cite
|
Sign up to set email alerts
|

Interactions between erythromycin, flunixin meglumine, levamisole and plant secondary metabolites towards bovine gastrointestinal motilityin vitro study

Abstract: Continued ingestion of plant secondary metabolites by ruminants can provoke pharmacological interactions with pharmaceutical agents used in animals. As some drugs and phytocompounds affect smooth muscle activity, the aim of this study was to verify the possible interaction between selected pharmaceutical agents and plant secondary metabolites towards bovine gastrointestinal motility. The interactions between phytocompounds-apigenin, quercetin, hederagenin, medicagenic acid-and medicines-erythromycin, flunixin … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 50 publications
0
1
0
Order By: Relevance
“…Although individual bioactive compounds may be present in this supplement their interactions cannot reliably be predicted. Mendel, Chłopecka, Dziekan, and Karlik (2018) demonstrated that certain plant secondary metabolites could enhance the action of prokinetic drugs in isolated bovine abomasal and duodenal smooth muscle. However, these effects were dose‐dependent and the flavonoids tested, quercetin and apigenin, abolished the contractile properties of all the prokinetic drugs at concentrations of 100 µM.…”
Section: Discussionmentioning
confidence: 99%
“…Although individual bioactive compounds may be present in this supplement their interactions cannot reliably be predicted. Mendel, Chłopecka, Dziekan, and Karlik (2018) demonstrated that certain plant secondary metabolites could enhance the action of prokinetic drugs in isolated bovine abomasal and duodenal smooth muscle. However, these effects were dose‐dependent and the flavonoids tested, quercetin and apigenin, abolished the contractile properties of all the prokinetic drugs at concentrations of 100 µM.…”
Section: Discussionmentioning
confidence: 99%